Ikada Y - Search Results

1

A new vitreal drug delivery system using an implantable biodegradable polymeric device.

Kimura H, Ogura Y, Hashizoe M, Nishiwaki H, Honda Y, Ikada Y. Kimura H, et al. Among authors: ikada y. Invest Ophthalmol Vis Sci. 1994 May;35(6):2815-9. Invest Ophthalmol Vis Sci. 1994. PMID: 8188476

2

Scleral plug of biodegradable polymers for controlled drug release in the vitreous.

Hashizoe M, Ogura Y, Kimura H, Moritera T, Honda Y, Kyo M, Hyon SH, Ikada Y. Hashizoe M, et al. Among authors: ikada y. Arch Ophthalmol. 1994 Oct;112(10):1380-4. doi: 10.1001/archopht.1994.01090220130035. Arch Ophthalmol. 1994. PMID: 7945044

3

In vitro phagocytosis of polylactide microspheres by retinal pigment epithelial cells and intracellular drug release.

Kimura H, Ogura Y, Moritera T, Honda Y, Tabata Y, Ikada Y. Kimura H, et al. Among authors: ikada y. Curr Eye Res. 1994 May;13(5):353-60. doi: 10.3109/02713689409167299. Curr Eye Res. 1994. PMID: 8055699

4

Feasibility of drug targeting to the retinal pigment epithelium with biodegradable microspheres.

Moritera T, Ogura Y, Yoshimura N, Kuriyama S, Honda Y, Tabata Y, Ikada Y. Moritera T, et al. Among authors: ikada y. Curr Eye Res. 1994 Mar;13(3):171-6. doi: 10.3109/02713689408995774. Curr Eye Res. 1994. PMID: 8194365

5

Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits.

Hashizoe M, Ogura Y, Takanashi T, Kunou N, Honda Y, Ikada Y. Hashizoe M, et al. Among authors: ikada y. Curr Eye Res. 1997 Jul;16(7):633-9. doi: 10.1076/ceyr.16.7.633.5063. Curr Eye Res. 1997. PMID: 9222079

6

Biodegradable scleral implant for intravitreal controlled release of fluconazole.

Miyamoto H, Ogura Y, Hashizoe M, Kunou N, Honda Y, Ikada Y. Miyamoto H, et al. Among authors: ikada y. Curr Eye Res. 1997 Sep;16(9):930-5. doi: 10.1076/ceyr.16.9.930.5042. Curr Eye Res. 1997. PMID: 9288455

7

Effect of focal X-ray irradiation on experimental choroidal neovascularization.

Miyamoto H, Kimura H, Yasukawa T, Honda Y, Tabata Y, Ikada Y, Sasai K, Ogura Y. Miyamoto H, et al. Among authors: ikada y. Invest Ophthalmol Vis Sci. 1999 Jun;40(7):1496-502. Invest Ophthalmol Vis Sci. 1999. PMID: 10359332

8

Targeted delivery of anti-angiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovascularization.

Yasukawa T, Kimura H, Tabata Y, Miyamoto H, Honda Y, Ikada Y, Ogura Y. Yasukawa T, et al. Among authors: ikada y. Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2690-6. Invest Ophthalmol Vis Sci. 1999. PMID: 10509667

9

Biodegradable scleral implant for intravitreal controlled release of ganciclovir.

Yasukawa T, Kimura H, Kunou N, Miyamoto H, Honda Y, Ogura Y, Ikada Y. Yasukawa T, et al. Among authors: ikada y. Graefes Arch Clin Exp Ophthalmol. 2000 Feb;238(2):186-90. doi: 10.1007/s004170050031. Graefes Arch Clin Exp Ophthalmol. 2000. PMID: 10766290

10

Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate.

Kunou N, Ogura Y, Honda Y, Hyon SH, Ikada Y. Kunou N, et al. Among authors: ikada y. J Biomed Mater Res. 2000 Sep 15;51(4):635-41. doi: 10.1002/1097-4636(20000915)51:4<635::aid-jbm11>3.0.co;2-o. J Biomed Mater Res. 2000. PMID: 10880111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters